Published in Autoimmun Rev on January 28, 2017
Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies. J Transl Med (2017) 0.75
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95
Complement factor H polymorphism and age-related macular degeneration. Science (2005) 17.79
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A (2005) 13.44
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 6.47
A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol (2002) 5.57
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol (2003) 5.22
Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol (2004) 5.14
Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat Immunol (2008) 4.17
The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2006) 3.60
The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res (2009) 3.40
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39
Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A (2006) 3.25
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts. Ann Med (2006) 2.99
Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92
Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87
Para-inflammation in the aging retina. Prog Retin Eye Res (2009) 2.71
Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 2.40
Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis (2007) 2.38
Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Aspects Med (2012) 2.37
The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol (2006) 2.37
Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem (2003) 2.30
Systemic complement activation in age-related macular degeneration. PLoS One (2008) 2.18
Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA (2006) 2.15
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell (2007) 1.93
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol (2004) 1.83
What are biomarkers? Curr Opin HIV AIDS (2010) 1.80
Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev (2009) 1.68
Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology (2011) 1.61
Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet (2010) 1.57
Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization? Arch Ophthalmol (2004) 1.57
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet (2015) 1.55
Age-related macular degeneration and the complement system. Immunobiology (2011) 1.52
Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res (2005) 1.50
α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol (2012) 1.48
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47
Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol (2011) 1.44
The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One (2008) 1.44
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res (2010) 1.39
Review of genetics in age related macular degeneration. Semin Ophthalmol (2007) 1.37
Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res (2008) 1.36
Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res (2013) 1.29
Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep (2012) 1.28
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun (1998) 1.28
Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp Eye Res (2011) 1.25
Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J Pathol (2013) 1.24
Age-related macular degeneration in the aspect of chronic low-grade inflammation (pathophysiological parainflammation). Mediators Inflamm (2014) 1.20
Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci (1993) 1.20
The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol (2007) 1.19
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation (2010) 1.18
Anatomy and development of the macula: specialisation and the vulnerability to macular degeneration. Clin Exp Optom (2005) 1.18
Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol (2014) 1.17
Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol (2010) 1.16
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol (2010) 1.12
C-reactive protein and complement factor H in aged human eyes and eyes with age-related macular degeneration. Br J Ophthalmol (2011) 1.09
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology (2005) 1.08
Differential involvement of phosphoinositide 3-kinase/Akt in human RPE MCP-1 and IL-8 expression. Invest Ophthalmol Vis Sci (2004) 1.07
Age-related macular degeneration and the role of the complement system. Mol Immunol (2015) 1.07
Discovery of carboxyethylpyrroles (CEPs): critical insights into AMD, autism, cancer, and wound healing from basic research on the chemistry of oxidized phospholipids. Chem Res Toxicol (2011) 1.05
Immune activation in retinal aging: a gene expression study. Invest Ophthalmol Vis Sci (2010) 1.05
Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr Eye Res (2007) 1.03
T cells and macrophages responding to oxidative damage cooperate in pathogenesis of a mouse model of age-related macular degeneration. PLoS One (2014) 1.01
Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology (1991) 0.99
Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr Eye Res (1993) 0.99
CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell Immunol (2011) 0.99
Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol (2012) 0.98
Inflammation and its role in age-related macular degeneration. Cell Mol Life Sci (2016) 0.97
Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp Mol Pathol (2011) 0.97
TGF-beta and IL-1 beta act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology (1995) 0.96
Immune cells in the human choroid. Br J Ophthalmol (2008) 0.95
The oxidative stress product carboxyethylpyrrole potentiates TLR2/TLR1 inflammatory signaling in macrophages. PLoS One (2014) 0.94
Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Meta-analysis. Am J Ophthalmol (2015) 0.93
Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 0.93
Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration. Am J Ophthalmol (2012) 0.93
Anti-alpha B-crystallin immunoreactivity in inflammatory nervous system diseases. J Neurol (2000) 0.92
Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration. PLoS One (2014) 0.91
Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease? Autoimmune Dis (2014) 0.91
Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol (2015) 0.90
Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non-small-cell lung cancer. Sci Rep (2015) 0.88
Serum cytokines as biomarkers for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2014) 0.87
Clinical characteristics and current treatment of age-related macular degeneration. Cold Spring Harb Perspect Med (2014) 0.87
Complement pathway biomarkers and age-related macular degeneration. Eye (Lond) (2015) 0.86
Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin Experiment Ophthalmol (2006) 0.84
Preclinical rheumatoid arthritis (autoantibodies): an updated review. Curr Rheumatol Rep (2014) 0.84
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration. Prog Retin Eye Res (2015) 0.83
Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration. BMC Ophthalmol (2014) 0.82
Age-related macular degeneration: Complement in action. Immunobiology (2015) 0.81
A role for IL-17 in age-related macular degeneration. Nat Rev Immunol (2013) 0.79
Identification of immunodominant epitopes of alpha-crystallins recognized by antibodies in sera of patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.77
Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants. Sci Rep (2016) 0.77
Aqueous humor cytokine profiling in patients with wet AMD. Mol Vis (2016) 0.77
Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology. Exp Dermatol (2016) 0.75